QSI icon

Quantum-Si Incorporated

1.16 USD
+0.02
1.75%
Updated Aug 26, 10:25 AM EDT
1 day
1.75%
5 days
14.85%
1 month
-35.20%
3 months
-39.58%
6 months
-22.15%
Year to date
-72.77%
1 year
22.11%
5 years
-88.26%
10 years
-88.26%
 

About: Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Employees: 143

0
Funds holding %
of 7,430 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

79% more capital invested

Capital invested by funds: $69.2M [Q1] → $124M (+$55M) [Q2]

67% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 33

10% more call options, than puts

Call options by funds: $2.33M | Put options by funds: $2.11M

3.37% more ownership

Funds ownership: 35.36% [Q1] → 38.73% (+3.37%) [Q2]

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

2% less funds holding

Funds holding: 134 [Q1] → 131 (-3) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for QSI.

Financial journalist opinion

Based on 9 articles about QSI published over the past 30 days

Neutral
Business Wire
1 week ago
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference.
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Neutral
Business Wire
1 week ago
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Business Wire
2 weeks ago
Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit.
Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit
Neutral
Zacks Investment Research
2 weeks ago
Quantum-Si's Q2 Loss In Line With Estimates, Revenues Rise Y/Y
QSI posts in-line Q2 loss and 12.4% revenue growth, but a sharp miss on estimates sends shares down nearly 5%.
Quantum-Si's Q2 Loss In Line With Estimates, Revenues Rise Y/Y
Neutral
The Motley Fool
2 weeks ago
Quantum-Si (QSI) Q2 Revenue Falls 47%
Quantum-Si (QSI), a developer of next-generation protein sequencing technology, reported its Q2 2025 earnings on August 5, 2025. The most significant news was a steep revenue shortfall, as GAAP sales came in at $0.59 million compared to analyst estimates of $1.11 million—a miss of nearly 46.7%.
Quantum-Si (QSI) Q2 Revenue Falls 47%
Neutral
Seeking Alpha
2 weeks ago
Quantum-Si incorporated (QSI) Q2 2025 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Jeffrey Alan Hawkins - President, CEO & Director Jeffry R. Keyes - CFO & Treasurer Risa Lindsay - Corporate Participant Conference Call Participants Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division Scott Robert Henry - Alliance Global Partners, Research Division Swayampakula Ramakanth - H.C.
Quantum-Si incorporated (QSI) Q2 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
2 weeks ago
Quantum-Si Incorporated (QSI) Reports Q2 Loss, Lags Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.16 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.16 per share a year ago.
Quantum-Si Incorporated (QSI) Reports Q2 Loss, Lags Revenue Estimates
Neutral
Business Wire
2 weeks ago
Quantum-Si Reports Second Quarter 2025 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Second Quarter 2025 Financial Results.
Quantum-Si Reports Second Quarter 2025 Financial Results
Positive
Zacks Investment Research
3 weeks ago
QSI Gears Up to Post Q2 Earnings: What's in Store for the Stock?
QuantumSi Incorporated eyes Q2 revenue surge as global traction, product launches, and Platinum platform adoption offset U.S. market headwinds.
QSI Gears Up to Post Q2 Earnings: What's in Store for the Stock?
Positive
Seeking Alpha
1 month ago
Quantum-Si Stock: A Small Position Is Warranted (Technical Analysis)
Quantum-Si shows bullish technical signals: trading above its 30-week EMA, strong momentum, positive volume trends, and outperforming the S&P 500 since April. Upcoming earnings are a key catalyst. Surpassing $1.28M revenue could trigger a significant rally, while a miss may lead to a sharp sell-off. Despite valuation concerns and NIH funding headwinds, international growth and U.S. non-academic segments provide optimism for revenue expansion.
Quantum-Si Stock: A Small Position Is Warranted (Technical Analysis)
Charts implemented using Lightweight Charts™